Quintiles is growing our investigator network to meet global demands to conduct biosimilar trials across a range of therapy areas. Whether you are already a Quintiles investigator or new to Quintiles, register your interest in becoming an investigator on biosimilar trials today!
Quintiles is your ideal clinical research partner in biosimilars development. We work with tens of thousands of research sites around the world and consistently demonstrate high standards of quality assurance and good clinical practice. We aim to offer investigators a high-quality and rewarding experience.
||Your patients can:
In 2012, Quintiles conducted a global survey of clinical investigators and found that more than 75% were interested in participating in biosimilar research, but still had a number of questions and concerns regarding the official definition of ‘similarity’, how this standard is enforced by regulatory authorities, whether licensed biosimilars are really safe to prescribe and the potential benefits of patient participation in biosimilar studies.
To address the need for education, Quintiles launched Biosimilars Knowledge Connect, a global initiative to inform investigators about biosimilars and their role in improving patient access to potentially life-saving biologic medicines. This initiative included personal outreach to investigators working with Quintiles, as well as the development of this website and a number of other educational resources that you can find within the Resources section.